Similar Papers

Paper Title
Journal
Date
Author
Real-world data studies in oncology: analysis of the Russian publications
V F Achikyan ... A A Kurylev
Real-World Data & Evidence | VOL. 4
V F Achikyan, et. al.V F Achikyan ... A A Kurylev
30 Mar 2024
848P Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801
...
Annals of Oncology | VOL. 33
, et. al. ...
01 Sep 2022
Eltrombopag in adult patients with immune thrombocytopenia in the real-world in France, including off-label use before 6 months of disease duration: The multicenter, prospective ELEXTRA study.
...
American Journal of Hematology | VOL. 97
, et. al. ...
06 Dec 2021
SYNERGIA-MOROCCO: EFFECTIVENESS OF HYPERTENSION MANAGEMENT WITH AN AMLODIPINE AND PERINDOPRIL ARGININE-BASED STRATEGY IN MOROCCO: STUDY DESIGN AND PRELIMINARY DATA
Selma Siham El Khayat ... Jean -Claude Mbanya
Journal of Hypertension | VOL. 42
Selma Siham El Khayat, et. al.Selma Siham El Khayat ... Jean -Claude Mbanya
01 May 2024
View more papers

More From: Pharmacoepidemiology and drug safety

Paper Title
Journal
Date
Author
-
-
Pharmacoepidemiology and Drug Safety | VOL. -
--
01 Feb 2025
Impact of Pharmacovigilance Interventions Targeting Fluoroquinolones on Antibiotic Use in the Netherlands and the United Kingdom.
Tomas Lasys ... Helga Gardarsdottir
Pharmacoepidemiology and drug safety | VOL. 34
Tomas Lasys, et. al.Tomas Lasys ... Helga Gardarsdottir
01 Feb 2025
Impact of Lookback Duration on the Performance of a Claims-Based Frailty Proxy in Women With Stage I-III Breast Cancer.
Emilie D Duchesneau ... Jennifer L Lund
Pharmacoepidemiology and drug safety | VOL. 34
Emilie D Duchesneau, et. al.Emilie D Duchesneau ... Jennifer L Lund
01 Feb 2025
Lessons Learned From Characterizing Long COVID Among US Medicare Beneficiaries.
Yun Lu ... Richard A Forshee
Pharmacoepidemiology and drug safety | VOL. 34
Yun Lu, et. al.Yun Lu ... Richard A Forshee
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.